Indoriv Clinical is an Indian contract research organization that provides services in clinical research, regulatory affairs, quality assurance and data management.

Jeevanam Biobank
Jeevanam or life as we know it, is a miracle in itself. There is beauty in the way our bodies have been intricately crafted to support us. We, at Jeevanam biobank, aim to add value to this very miracle. Our exhaustive Biorepository of high quality, well characterized samples and data are readily available for analysis. Armed with data, we aim to be future ready to deal with upcoming yet unknown diseases.

When coupled with subject data from questionnaires and medical records, our biobank can be helpful in researching complicated diseases like cancer, cardiovascular disease, and diabetes. The growth of computer technology, post-genomic analysis, human genome sequencing, and bioinformatics has had a significant positive impact on the biobanking sector. By making high- quality, carefully described, and related samples and data easily accessible for study, our biobank plays a crucial part in advancing research and enhancing healthcare delivery. These collections, which preserve human biological samples in cryogenic environments, have the potential to change medicine by giving researchers access to population-wide data that will allow them to investigate the link between heredity and disease. Every year, investigators and researchers who use the biobanking technique to study diseases help save numerous precious lives.

Clinical Research

A regulated protocol is followed during a clinical trial, which is a subset of clinical research. The main purpose of clinical trials is to gather information about the safety and efficacy of newly developed drugs. For the medicine to be further approved and put on the market, clinical trial data is necessary.

We have established a strong track record of bringing diagnostics and treatments to market owing to our cutting-edge facilities and global network of investigators. India accounts for 18% of global disease burden but fewer than 2% of global clinical trials. The dearth of Clinical Trial Sites is one of the main causes of this phenomenon.
Indoriv Clinical wants to become the first of its kind nation-wide organized site management company offering one stop solution to CROs and Pharma companies.
Our exposure in clinical trials :
Passed USFDA audits with no findings in Form 483
Passed DCGI audit 2017, 2018 & 2019 with no major findings in all our sites
Conducted more than 300+ clinical trials
Worked with clients in the U.S. and Europe